Bellevue Group Ag Alnylam Pharmaceuticals, Inc. Transaction History

Bellevue Group Ag

  • $4.31 Billion
  • Q1 2025

A detailed history of Bellevue Group Ag transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 768,147 shares of ALNY stock, worth $250 Million. This represents 4.81% of its overall portfolio holdings.

Number of Shares
768,147
Previous 770,268 0.28%
Holding current value
$250 Million
Previous $181 Million 14.44%
% of portfolio
4.81%
Previous 3.61%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$233.07 - $290.7 $494,341 - $616,574
-2,121 Reduced 0.28%
768,147 $207 Million
Q4 2024

Feb 14, 2025
SELL
$232.27 - $300.43 $9.02 Million - $11.7 Million
-38,827 Reduced 4.8%
770,268 $181 Million
Q3 2024

Nov 14, 2024
SELL
$233.81 - $287.01 $25.9 Million - $31.8 Million
-110,739 Reduced 12.04%
809,095 $223 Million
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $222,130 - $382,850
1,550 Added 0.17%
919,834 $224 Million
Q1 2024

May 15, 2024
BUY
$146.51 - $198.2 $4.83 Million - $6.53 Million
32,966 Added 3.72%
918,284 $137 Million
Q4 2023

Feb 14, 2024
SELL
$151.41 - $196.57 $1.37 Million - $1.77 Million
-9,027 Reduced 1.01%
885,318 $169 Million
Q3 2023

Nov 14, 2023
SELL
$170.77 - $211.65 $905,934 - $1.12 Million
-5,305 Reduced 0.59%
894,345 $158 Million
Q2 2023

Aug 14, 2023
BUY
$185.01 - $212.05 $3.03 Million - $3.48 Million
16,400 Added 1.86%
899,650 $171 Million
Q1 2023

May 15, 2023
SELL
$182.66 - $235.53 $6.93 Million - $8.94 Million
-37,963 Reduced 4.12%
883,250 $177 Million
Q4 2022

Feb 14, 2023
SELL
$185.53 - $241.31 $6.6 Million - $8.58 Million
-35,549 Reduced 3.72%
921,213 $219 Million
Q3 2022

Nov 14, 2022
SELL
$138.54 - $232.0 $14.1 Million - $23.5 Million
-101,424 Reduced 9.58%
956,762 $192 Million
Q2 2022

Aug 11, 2022
SELL
$120.42 - $169.29 $20.6 Million - $29 Million
-171,377 Reduced 13.94%
1,058,186 $154 Million
Q1 2022

May 13, 2022
SELL
$127.18 - $173.91 $13.4 Million - $18.4 Million
-105,577 Reduced 7.91%
1,229,563 $201 Million
Q4 2021

Feb 10, 2022
SELL
$159.56 - $209.29 $11.7 Million - $15.3 Million
-73,278 Reduced 5.2%
1,335,140 $226 Million
Q3 2021

Nov 12, 2021
SELL
$169.75 - $207.73 $23.9 Million - $29.2 Million
-140,674 Reduced 9.08%
1,408,418 $266 Million
Q2 2021

Aug 12, 2021
SELL
$128.63 - $176.89 $10 Million - $13.8 Million
-78,022 Reduced 4.8%
1,549,092 $263 Million
Q1 2021

May 12, 2021
BUY
$126.83 - $175.69 $2.99 Million - $4.15 Million
23,614 Added 1.47%
1,627,114 $230 Million
Q4 2020

Feb 16, 2021
BUY
$122.97 - $147.0 $5.37 Million - $6.42 Million
43,695 Added 2.8%
1,603,500 $208 Million
Q3 2020

Nov 16, 2020
SELL
$121.19 - $165.49 $6.09 Million - $8.32 Million
-50,260 Reduced 3.12%
1,559,805 $227 Million
Q2 2020

Aug 13, 2020
SELL
$104.21 - $156.44 $17.2 Million - $25.8 Million
-165,199 Reduced 9.31%
1,610,065 $238 Million
Q1 2020

May 14, 2020
SELL
$93.12 - $133.99 $8.34 Million - $12 Million
-89,519 Reduced 4.8%
1,775,264 $193 Million
Q4 2019

Feb 14, 2020
SELL
$74.51 - $124.23 $7.47 Million - $12.5 Million
-100,289 Reduced 5.1%
1,864,783 $215 Million
Q3 2019

Nov 14, 2019
BUY
$70.9 - $87.82 $2.67 Million - $3.31 Million
37,678 Added 1.95%
1,965,072 $158 Million
Q2 2019

Aug 14, 2019
BUY
$65.86 - $92.79 $109 Million - $154 Million
1,660,089 Added 621.05%
1,927,394 $140 Million
Q1 2019

May 15, 2019
BUY
$72.76 - $93.45 $3.12 Million - $4.01 Million
42,920 Added 19.13%
267,305 $25 Million
Q4 2018

Feb 12, 2019
BUY
$62.67 - $88.33 $281,638 - $396,955
4,494 Added 2.04%
224,385 $16.4 Million
Q3 2018

Nov 13, 2018
BUY
$87.52 - $122.67 $10.2 Million - $14.3 Million
116,391 Added 112.46%
219,891 $19.2 Million
Q2 2018

Aug 07, 2018
BUY
$88.31 - $107.8 $7.22 Million - $8.81 Million
81,750 Added 375.86%
103,500 $10.2 Million
Q1 2018

May 09, 2018
SELL
$115.92 - $148.54 $40,572 - $51,989
-350 Reduced 1.58%
21,750 $2.59 Million
Q4 2017

Feb 14, 2018
SELL
$114.49 - $139.98 $6.12 Million - $7.49 Million
-53,493 Reduced 70.76%
22,100 $2.81 Million
Q3 2017

Nov 13, 2017
SELL
$72.53 - $118.27 $3.59 Million - $5.85 Million
-49,436 Reduced 39.54%
75,593 $8.88 Million
Q2 2017

Aug 14, 2017
BUY
N/A
125,029
125,029 $9.97 Million

Others Institutions Holding ALNY

# of Institutions
721
Shares Held
111M
Call Options Held
978K
Put Options Held
881K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $40.1B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email